FCA: Odey showed 'disregard, disrespect and contempt' in dismissing executive committee Investing March 11, 2026 The Financial Conduct Authority has argued fund manager Crispin Odey demonstrated “disregard” and “disrespect” to the executive committee of Odey…
AI Robotics Startup Rhoda Hits US$1.7 Billion Valuation after Successful Funding Round Investing March 11, 2026 Giann Liguid is a graduate of Ateneo De Manila University with an AB in Interdisciplinary Studies. With a diverse writing…
Benchmark: Surging Copper Prices Highlight Looming Global Supply Challenges Investing March 11, 2026 Dean has been writing in one form or another since penning stage plays in his youth. He is a graduate…
Spartan Metals: High-grade Critical Metals in Nevada to Potentially Address Domestic Supply Gaps Investing March 11, 2026 Pia oversees the Production teams in Vancouver and Toronto. She was the first production manager at INN in 2008, left…
Brixton Metals Targets High-grade Silver and Copper in BC and Ontario Investing March 11, 2026 Pia oversees the Production teams in Vancouver and Toronto. She was the first production manager at INN in 2008, left…
One Bullion Advances Toward Drill-Ready Targets at Botswana Gold Assets Investing March 11, 2026 Pia oversees the Production teams in Vancouver and Toronto. She was the first production manager at INN in 2008, left…
Tavi Costa: Gold, Silver Stocks to Rerate, “Explosive” Energy, Copper Opportunities Investing March 11, 2026 With an eye for detail and over a decade of experience covering the mining and metals sector, Charlotte is passionate…
David Erfle: Gold, Silver Under Pressure, Key Price Levels to Watch Investing March 10, 2026 With an eye for detail and over a decade of experience covering the mining and metals sector, Charlotte is passionate…
Canada’s Junior Miners Still Facing Challenging Financial Climate as Metals Prices Climb Investing March 10, 2026 Melissa Pistilli has been reporting on the markets and educating investors since 2006. She has covered a wide variety of…
SVN-114 selected as the lead candidate for PTSD discovery programme Investing March 10, 2026 Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (“CNS”) disorders,…
